Triethylamine → 2-Furan-2-yl-5-[4-(5-methyl-isoxazol-3-ylmethyl)-piperazin-1-yl]-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ylamine
Reaction equation
S([O-])(=O)(=O)C.[CH3:6][C:7]1[O:11][N:10]=[C:9]([CH2:12]OS(C)(=O)=O)[CH:8]=1.[O:18]1[CH:22]=[CH:21][CH:20]=[C:19]1[C:23]1[N:38]=[C:26]2[N:27]=[C:28]([N:32]3[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]3)[N:29]=[C:30]([NH2:31])[N:25]2[N:24]=1.CCN(CC)CC>CC#N>[O:18]1[CH:22]=[CH:21][CH:20]=[C:19]1[C:23]1[N:38]=[C:26]2[N:27]=[C:28]([N:32]3[CH2:37][CH2:36][N:35]([CH2:12][C:9]4[CH:8]=[C:7]([CH3:6])[O:11][N:10]=4)[CH2:34][CH2:33]3)[N:29]=[C:30]([NH2:31])[N:25]2[N:24]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
The mesylate derivative from subpart (a) above (0.28 mmol) was added to a solution of 2-furan-2-yl-5-piperazin-1-yl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ylamine (0.14 mmol; see Example 1(a) above) and Et3N (0.3 mmol) in 3 mL of CH3CN. The resulting reaction mixture was stirred at room temperature for 18 hours. It was then concentrated and purified by preparative HPLC using a mixture of aqueous CH3CN that has been buffered with 0.1% TFA.
Workup
- customThe resulting reaction mixture
- concentrationIt was then concentrated
- custompurified by preparative HPLC
- additiona mixture of aqueous CH3CN that
Sources & evidence
- ORD record
- ord-c71fd56e090c492ab1642de83a7b04ab
- Source dataset
- uspto-grants-2007_10
- Patent number
- US07285550B2
Reaction notes
Loading…